logo BDSP

Base documentaire

  1. The relative community burden of otitis media and varicella.

    Article - En anglais

    Otitis media is a common and costly condition of childhood, with a great potential for cost savings from an effective vaccine.

    We present a population-based survey of the family burden of otitis media and compare it with another common childhood illness, varicella, for which vaccine prevention is available and cost-effective.

    We report yearly rates of affected children, complications, medication use, hospitalizations, parental work absences, and use of special sick-child day care in a population of 4557 households containing 9047 children younger than 13 years of age.

    Of the 9047 children in the sample, 26.1% were affected by otitis media in the year of the study ; 68% of children in the second year of life had at least one episode.

    About one third of families lost workdays due to otitis media in their children, with an overall average loss of about 3 hours per affected child.

    Compared with the community burden of varicella, otitis media involves a greater total burden in terms of the number of affected children, the number of episodes, physician visits, prescription drugs, hospitalizations, and surgical procedures.

    Work loss was 3.4 times greater per family with a varicella case, but the number of families affected by otitis media was 3.3 times greater than for varicella, so that the total amount of family work loss was about the same for both illnesses for the year. (...)

    Mots-clés Pascal : Analyse coût efficacité, Otite moyenne, Varicelle, Virose, Infection, Enfant, Homme, Etude comparative, Fréquence apparition, Coût moyen, Vaccination, Chimiothérapie, Prévention, Epidémiologie, Etats Unis, Amérique du Nord, Amérique, Traitement, ORL pathologie, Oreille moyenne pathologie

    Mots-clés Pascal anglais : Cost efficiency analysis, Otitis media, Varicella, Viral disease, Infection, Child, Human, Comparative study, Occurrence frequency, Average cost, Vaccination, Chemotherapy, Prevention, Epidemiology, United States, North America, America, Treatment, ENT disease, Middle ear disease

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 97-0027960

    Code Inist : 002B30A03B. Création : 21/05/1997.